MedPath

Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane Techniques

Not Applicable
Completed
Conditions
Aphakia
Registration Number
NCT06389643
Lead Sponsor
Military Institute od Medicine National Research Institute
Brief Summary

Comparison of safety and efficacy of two scleral fixation intraocular lens (IOL) methods of four-point scleral fixation ( Akreos AO60) and the Yamane technique (AcrySof MA60AC)

Detailed Description

Purpose of the study is to compare two methods of scleral fixation of IOL: two-point fixation of AcrySof MA60AC IOL (Alcon) using Yamane technique and four-point fixation of the Akreos AO60 IOL (Bausch \& Lomb) using polypropylene suture. The investigators rated the BCVA, refractive outcomes, intraocular pressure, and also determined intra- and postoperative complications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • only adult men and women with aphakia without capsular support
Exclusion Criteria
  • Fuchs' dystrophy
  • corneal haze or scarring
  • history of corneal transplantation
  • astigmatism of more than 2,0D
  • clinically active uveitis
  • advanced glaucoma
  • macular diseases that affect visual acuity (age-related macular degeneration, diabetic maculopathy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
RE12 months after surgery

Postoperative total refractive error

ECCbefore and 12 months after surgery

corneal endothelial cell density

BCVAbefore and 12 months after surgery

The change of best- corrected visual acuity

Secondary Outcome Measures
NameTimeMethod
Number of complicationsfrom day 1 until 12 months after surgery

Rate of complications

Trial Locations

Locations (1)

Military Institute of Medicine - National Research Institute

🇵🇱

Warsaw, Poland

Military Institute of Medicine - National Research Institute
🇵🇱Warsaw, Poland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.